Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
Active, not recruiting · NCT02835222 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients | Untreated Adult Acute Myeloid Leukemia | Active, not recruiting | Phase 2 | 2026-08-20 | NCT02835222 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Wake Forest University Health Sciences | 284 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Comprehensive Cancer Center of Wake Forest University | Winston-Salem | United States | 1 |
| Virginia Commonwealth University Massey Cancer Center | Richmond | United States | 17 |